Patents by Inventor Marcos GRANDA

Marcos GRANDA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR PRODUCING GRAPHENE WITH TUNABLE PROPERTIES BY A MULTI-STEP THERMAL REDUCTION PROCESS
    Publication number: 20170260055
    Abstract: A process for the preparation of graphene includes the steps of a) providing flash thermal treatment of a graphite oxide at a temperature up to 700° C. sufficient to produce exfoliation and under inert atmosphere and b) cooling the material obtained in the previous step below 90° C. The method further includes the step of c) heating the material resulting from the previous step under inert atmosphere at a temperature which is higher than the temperature of step a), wherein the heating rate is between 1 and 15° C./min. The graphenes obtained from the process exhibit excellent physico-chemical properties.
    Type: Application
    Filed: September 17, 2015
    Publication date: September 14, 2017
    Applicant: REPSOL, S.A.
    Inventors: Antonio PÁEZ DUEÑAS, Jesús GARCÍA SAN LUIS, Patricia ÁLVAREZ RODRÍGUEZ, Marcos GRANDA, Clara BLANCO RODRÍGUEZ, Ricardo SANTAMARÍA RAMÍREZ, Patricia BLANCO, Laura FERNÁNDEZ, Rosa María MENÉNDEZ LÓPEZ, Fernando CALLE GÓMEZ
  • Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain
    Patent number: RE49847
    Abstract: The invention provides compositions and methods for treating diseases associated with expression of CD20 or CD22. The invention also relates to chimeric antigen receptor (CAR) specific to CD20 or CD22, vectors encoding the same, and recombinant T or natural killer (NK) cells comprising the CD20 CAR or CD22 CAR. The invention also includes methods of administering a genetically modified T cell or NK cell expressing a CAR that comprises a CD20 or CD22 binding domain.
    Type: Grant
    Filed: January 5, 2022
    Date of Patent: February 27, 2024
    Assignees: Novartis AG, The Trustees of the University of Pennsylvania
    Inventors: Barbara Brannetti, Jennifer Brogdon, Boris Engels, Brian Granda, Lu Huang, Ming Lei, Na Li, Jimin Zhang, Carla Guimaraes, Saar Gill, Marco Ruella, Regina M. Young